Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Therapy in Pediatric Graves' Disease
NCT07369063Phase 2Active, not recruiting
- Sponsor
- Northwell Health
- Start
- Aug 2025
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vitamin d in Graves' disease (2 arms), sponsored by Northwell Health. Primary endpoints: Recruitment Rate at 1 year, Adherence Rate at 24 weeks and 2 more. Started Aug 2025; status: active, not recruiting.
02
Drugs
vitamin d
03
Conditions
Graves' disease
Beyond the preview
Go deeper on NCT07369063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07369063.